70564-802 : Fulyzaq 125 mg Oral Tablet, Coated
| NDC: | 70564-802 |
| Labeler: | Napo Pharmaceuticals, Inc. |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Fulyzaq |
| Dosage Form: | Oral Tablet, Coated |
| Application #: | NDA202292 |
| Rev. Date: |
Appearance:
| Markings: | 125SLXP |
| Shapes: |
Oval |
| Colors: |
 White |
| Size (mm): | 16 |
| Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. | |
NDC Package Codes:
- 70564-802-02: 60 TABLET, COATED IN 1 BOTTLE (70564‑802‑02)
- 70564-802-60: 60 TABLET, COATED IN 1 BOTTLE (70564‑802‑60)
Active Ingredients:
- Crofelemer
Dosage Strength:
- 125 mg
Inactive Ingredients:
- Cellulose, Microcrystalline
- Croscarmellose Sodium
- Silicon Dioxide
- Magnesium Stearate
- Ethyl Acrylate
- Talc
- Triethyl Citrate
- Xanthan Gum
- Titanium Dioxide
- Propylparaben
- Methylparaben
Pharmaceutical Classes:
- Antidiarrheal [EPC]
Related Products:
Based on records with the same trade name.- 65649-802 Fulyzaq 125 mg Enteric Coated Tablet by Salix Pharmaceuticals, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 70558-0011Next: 70565-580 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.